At six months, glutathione levels increased 30-35% in erythrocytes, plasma, and lymphocytes, accompanied by significant reductions in oxidative stress markers including 35% decreases in plasma 8-isoprostane
The bisphenol A + propolis 250 mg/kg group exhibited substantial histological improvement with restoration of tubular architecture, reduced inflammatory infiltration, and better-preserved glomerular morphology, approaching near-normal renal tissue structure
It also stimulates insulin secretion and reduces glucagon secretion in a glucose-dependent manner
GLP-1 therapies are not recommended in people with a personal or family history of medullary thyroid cancer or Multiple Endocrine Neoplasia type 2 (MEN2)
Glutathione IV therapy, by reducing oxidative stress and supporting cellular repair, may help alleviate these symptoms, making the detoxification process more comfortable and manageable